$36.13 -0.91 (-2.46%)
2/10/2012 4:00 PM

Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Featured Broker Partners


Advertisement